scispace - formally typeset
Open AccessJournal ArticleDOI

Leaky gut: mechanisms, measurement and clinical implications in humans.

Michael Camilleri
- 01 Aug 2019 - 
- Vol. 68, Iss: 8, pp 1516-1526
Reads0
Chats0
TLDR
Clinicians are to discuss the components of the intestinal barrier, the diverse measurements of intestinal permeability, their perturbation in non-inflammatory ‘stressed states’ and the impact of treatment with dietary factors.
Abstract
The objectives of this review on 'leaky gut' for clinicians are to discuss the components of the intestinal barrier, the diverse measurements of intestinal permeability, their perturbation in non-inflammatory 'stressed states' and the impact of treatment with dietary factors. Information on 'healthy' or 'leaky' gut in the public domain requires confirmation before endorsing dietary exclusions, replacement with non-irritating foods (such as fermented foods) or use of supplements to repair the damage. The intestinal barrier includes surface mucus, epithelial layer and immune defences. Epithelial permeability results from increased paracellular transport, apoptosis or transcellular permeability. Barrier function can be tested in vivo using orally administered probe molecules or in vitro using mucosal biopsies from humans, exposing the colonic mucosa from rats or mice or cell layers to extracts of colonic mucosa or stool from human patients. Assessment of intestinal barrier requires measurements beyond the epithelial layer. 'Stress' disorders such as endurance exercise, non-steroidal anti-inflammatory drugs administration, pregnancy and surfactants (such as bile acids and dietary factors such as emulsifiers) increase permeability. Dietary factors can reverse intestinal leakiness and mucosal damage in the 'stress' disorders. Whereas inflammatory or ulcerating intestinal diseases result in leaky gut, no such disease can be cured by simply normalising intestinal barrier function. It is still unproven that restoring barrier function can ameliorate clinical manifestations in GI or systemic diseases. Clinicians should be aware of the potential of barrier dysfunction in GI diseases and of the barrier as a target for future therapy.

read more

Citations
More filters
Journal ArticleDOI

Mucus barrier, mucins and gut microbiota: the expected slimy partners?

TL;DR: Different aspects of the mucus layer are debated by focusing on its chemical composition, regulation of synthesis and degradation by the microbiota as well as some characteristics of the slime layer in both physiological and pathological situations.
Journal ArticleDOI

Hallmarks of health.

TL;DR: This work endeavors to define health as a compendium of organizational and dynamic features that maintain physiology, including features of spatial compartmentalization, maintenance of homeostasis over time, and an array of adequate responses to stress.
Journal ArticleDOI

Regulation of Intestinal Barrier Function by Microbial Metabolites.

TL;DR: A review of recent advances on Gut microbial metabolites in the regulation of intestinal barrier function is presented in this paper, which mainly points to a small group of shared pathways that control gut barrier functions.
Journal ArticleDOI

Novel concepts in the pathophysiology and treatment of functional dyspepsia

TL;DR: Recent advances in the diagnosis and treatment of functional dyspepsia with a focus on the duodenum are summarized.
References
More filters
Journal ArticleDOI

Randomized controlled trial.

Journal ArticleDOI

Intestinal mucosal barrier function in health and disease.

TL;DR: Recent advances have uncovered mechanisms by which the intestinal mucosal barrier is regulated in response to physiological and immunological stimuli, along with evidence that this regulation shapes mucosal immune responses in the gut and, when dysfunctional, may contribute to disease.
Journal ArticleDOI

Cytokines sing the blues: inflammation and the pathogenesis of depression

TL;DR: These findings suggest that targeting proinflammatory cytokines and their signaling pathways might represent a novel strategy to treat depression.
Journal ArticleDOI

Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome

TL;DR: Results support the emerging concept that perturbed host–microbiota interactions resulting in low-grade inflammation can promote adiposity and its associated metabolic effects and suggest that the broad use of emulsifying agents might be contributing to an increased societal incidence of obesity/metabolic syndrome and other chronic inflammatory diseases.
Related Papers (5)